Concepedia

Greg Galler

GG

Statistics

Publications

14

Citations

4.5K

H-Index

14

Active since

1994

Affiliations

Kelsey Research Foundation(Current)

Clinical Research Institute

Duke University

Johns Hopkins University

Indiana University – Purdue University Indianapolis

Greg Galler is an author at Kelsey Research Foundation specializing in medicine, hepatology, and hepatitis c.

Top concepts

Publications per year

1994–2020

14

Publications

14

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Simon Lichtiger, D. H. Present, Asher Kornbluth et al. · New England Journal of Medicine · 1994 · 1.7K citations

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski et al. · Gastroenterology · 2010 · 723 citations · Full text

, , +11

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1

Ira M. Jacobson, Robert S. Brown, Jonathan McCone et al. · Hepatology · 2007 · 76 citations

1–5 of 14